Biortica is Leading the Charge to Meet Patients’ Medicinal Cannabis Requirements with Australian-Grown Crops

Biortica Agrimed, a leading name in Australia’s medicinal cannabis sector, continues to prioritise patient care through the expansion of its wholly owned subsidiary, Green Farmers. This strategic growth responds to increasing demand for locally cultivated, high-quality medicinal cannabis from patients and B2B partners across Australia. 

Green Farmers has established itself as a trusted producer by prioritising local supply chains, ensuring improved product consistency, maximising shelf life, and the ability to respond swiftly to market demands. In alignment with Biortica Agrimed’s mission to enhance patient care, Green Farmers is increasing its cultivation capacity fivefold over the next 12 months. 

The company’s existing 4,000-square-meter facility will be bolstered by an additional 6,000 square meters in Victoria, set to come online by March this year. Additionally, the retrofit on the 10,000-square-meter facility in the Lismore hinterland is expected to be operational by September this year. This expansion ensures year-round production through advanced glasshouse technology, eliminating delays caused by international shipments and complex import permits. 

Green Farmers Victorian Glass Houses

“Biortica Agrimed remains committed to ensuring patients and partners have access to reliable, high-quality medicinal cannabis,” said a Kathleen Ward, Chief Operating Officer at Biortica Agrimed. “Green Farmers’ expansion reflects our dedication to improving local supply chains, enhancing product availability, and supporting the Australian medicinal cannabis industry.”

Kathleen Ward, Chief Operation Officer of Biortica Agrimed.

The expansion provides a direct response to growing patient needs and feedback from leaders such as Suzette Luyken and the Legalise Cannabis Queensland Party (LCQP) as reported by Simon Mumford in the Lismore App. By investing in local cultivation infrastructure, Biortica Agrimed and Green Farmers are improving product availability and consistency for patients across Australia. 

“There are a lot of reasons why the increased footprint is important to the Australian medicinal cannabis industry” said Managing Director Tom Varga. “Yes, we are providing increased reliability and fresher product to Australian patients but we are also creating local jobs for Australia at a time when the economy needs it the most. Over 150 jobs will be created across both expansions. Add to this locally sourced product not being impacted by increasing freight costs and the falling Australian dollar and you have better patient accesses, protection from rising costs and job creation in Australia. Few companies or industries can claim that right now”.

Tom Varga, Managing Director of Biortica Agrimed.

 
Biortica is currently in the process of a reverse takeover via a DOCA of Bod Sciences (ASX:BOD) which will see the company have greater access to capital for future expansion. With over 80% of all medicinal cannabis products imported into Australia this provides significant scope for future growth and acquisitions.